Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




First-Of-Its-Kind Surgical Technology Platform Fuses Light Field Imaging Technology with AI

By HospiMedica International staff writers
Posted on 17 Oct 2023

For the first time, an artificial intelligence (AI)--powered surgical navigation system that leverages light field technology to offer real-time 3D views of surgical procedures has been successfully used in humans. More...

Proprio (Seattle, WA, USA) has announced the successful first-in-human use of its surgical technology platform, Paradigm, which combines light field imaging technology with AI to provide surgical teams with 3D visualization of the anatomical structures as well as surgical environment. Through an assortment of sophisticated sensors and cameras, the system captures high-quality multimodal images during surgery. These images are then integrated with scans taken before the operation to offer surgeons a real-time map of the anatomical structures. This marks an advancement over existing methods, which often involve expensive and radiation-heavy scans that can interrupt the workflow in a clinical setting.

The Paradigm system addresses a variety of pain points commonly encountered in surgical settings. For instance, it minimizes radiation exposure, enhances workflow efficiency, expedites the patient registration process, and continuously collects data. The platform gathers extensive preoperative and intraoperative data to assist in future surgical planning, thereby elevating the precision and efficacy of surgical procedures. Paradigm has received FDA 510(k) clearance and is now being introduced in select hospitals both in the United States and internationally.

"The successful first-in-human use of Paradigm marks a pivotal milestone in our journey to enhance the future of surgery," said Gabriel Jones, CEO and co-founder of Proprio. "We are honored by this validation of the potential of our platform to reshape surgical practices and drive meaningful reductions in costs, increasing access to essential healthcare."

Related Links:
Proprio 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.